Activity in this selectionMar 31, 2026 · Mar 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $1.2M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionNanoZymeXDevelops lipid nanoparticle-based platform for enzyme replacement therapy to treat rare genetic d...
Role not disclosedRhonexumDevelops electronics for quantum computing at cryogenic temperatures
Role not disclosed